Cell death-inducing fused gene acting specifically on cancer and gene product thereof

Details for Australian Patent Application No. 2004223546 (hide)

Owner Nippon Medical School Foundation

Inventors Ohta, Shigeo; Asoh, Sadamitsu

Agent FB Rice

Pub. Number AU-A-2004223546

PCT Pub. Number WO2004/085653

Priority 2003-081337 24.03.03 JP

Filing date 23 March 2004

Wipo publication date 7 October 2004

International Classifications

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C07K 014/47 Peptides having more than 20 amino acids

C07K 019/00 Hybrid peptides

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07K 014/44 Peptides having more than 20 amino acids

A61P 035/00 Antineoplastic agents

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/085653 Priority application(s): WO2004/085653

24 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004223547-Indoor Unit of an Air Conditioner

2004223523-A method for monitoring a highresistivity reservoir rock formation